Mineralys Therapeutics Stock Forward View - Accumulation Distribution
| MLYS Stock | 30.89 1.20 3.74% |
Mineralys Stock outlook is based on your current time horizon.
At this time, the value of RSI of Mineralys Therapeutics' share price is approaching 39. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Mineralys Therapeutics, making its price go up or down. Momentum 39
Sell Extended
Oversold | Overbought |
Using Mineralys Therapeutics hype-based prediction, you can estimate the value of Mineralys Therapeutics Common from the perspective of Mineralys Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Mineralys Therapeutics after-hype prediction price | USD 30.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mineralys | Build AI portfolio with Mineralys Stock |
Mineralys Therapeutics Additional Predictive Modules
Most predictive techniques to examine Mineralys price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mineralys using various technical indicators. When you analyze Mineralys charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 42858.75 | 0.0479 |
| Check Mineralys Therapeutics Volatility | Backtest Mineralys Therapeutics | Information Ratio |
Mineralys Therapeutics Trading Date Momentum
| On February 01 2026 Mineralys Therapeutics Common was traded for 30.89 at the closing time. The top price for the day was 32.34 and the lowest listed price was 30.79 . There was no trading activity during the period 0.0. Lack of trading volume on February 1, 2026 did not cause price change. The trading delta at closing time against the current closing price is 3.04% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Mineralys Therapeutics to competition |
Other Forecasting Options for Mineralys Therapeutics
For every potential investor in Mineralys, whether a beginner or expert, Mineralys Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Mineralys Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Mineralys. Basic forecasting techniques help filter out the noise by identifying Mineralys Therapeutics' price trends.Mineralys Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mineralys Therapeutics stock to make a market-neutral strategy. Peer analysis of Mineralys Therapeutics could also be used in its relative valuation, which is a method of valuing Mineralys Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Mineralys Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Mineralys Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mineralys Therapeutics shares will generate the highest return on investment. By undertsting and applying Mineralys Therapeutics stock market strength indicators, traders can identify Mineralys Therapeutics Common entry and exit signals to maximize returns.
Mineralys Therapeutics Risk Indicators
The analysis of Mineralys Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Mineralys Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mineralys stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.43 | |||
| Standard Deviation | 3.88 | |||
| Variance | 15.03 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Mineralys Therapeutics
The number of cover stories for Mineralys Therapeutics depends on current market conditions and Mineralys Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mineralys Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mineralys Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Mineralys Therapeutics Short Properties
Mineralys Therapeutics' future price predictability will typically decrease when Mineralys Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mineralys Therapeutics Common often depends not only on the future outlook of the potential Mineralys Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mineralys Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.5 M | |
| Cash And Short Term Investments | 198.2 M |
Additional Tools for Mineralys Stock Analysis
When running Mineralys Therapeutics' price analysis, check to measure Mineralys Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mineralys Therapeutics is operating at the current time. Most of Mineralys Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mineralys Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mineralys Therapeutics' price. Additionally, you may evaluate how the addition of Mineralys Therapeutics to your portfolios can decrease your overall portfolio volatility.